Evaluation of the performance, operability, and safety of Plasauto μ, a new type of machine for cell‐free and concentrated ascites reinfusion therapy, in a postmarketing clinical study

Author:

Hasegawa Midori1,Matsushita Hiromichi2,Yahata Kensei3,Sugawara Akira4,Ishibashi Yoshitaka5,Kawahara Ryoko6,Hamasaki Yoshifumi7,Kanno Hitoshi8,Yamada Sachie9,Nii Norio9,Kato Masao9,Ohashi Atsushi10,Koide Shigehisa1,Hayashi Hiroki1,Yuzawa Yukio1,Tsuboi Naotake1

Affiliation:

1. Department of Nephrology Fujita Health University School of Medicine Toyoake Aichi Japan

2. National Cancer Center Hospital Chuo‐ku Tokyo Japan

3. Japanese Red Cross Osaka Hospital Tennoji‐ku Osaka Japan

4. Shizuoka General Hospital Aoi‐ku Shizuoka Japan

5. Japanese Red Cross Medical Center Shibuya‐ku Tokyo Japan

6. The Cancer Institute Hospital of JFCR Koto‐ku Tokyo Japan

7. The University of Tokyo Hospital Bunkyo‐ku Tokyo Japan

8. Tokyo Women's Medical University Hospital Shinjuku‐ku Tokyo Japan

9. Center of Blood Purification Fujita Health University Hospital Toyoaka Aichi Japan

10. Faculty of Clinical Engineering Fujita Health University School of Health Sciences Toyoaka Aichi Japan

Publisher

Wiley

Subject

Nephrology,Hematology

Cited by 1 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3